Logo

EPA’s New Pharmaceutical Rule: Relief for Healthcare Facilities and Our Water Sources

Category:
Author: Marketing
Date: February 3, 2024

Background
When initially written, RCRA hazardous waste provisions were almost entirely focused on wastes generated by industrial facilities. These waste streams are few in number when compared to healthcare facilities, which could have thousands of medications on hand at any one time. Certain pharmaceuticals are regulated as hazardous waste under RCRA when discarded.

The EPA has long been aware that the method for managing used or unused pharmaceuticals has been to flush them down the sewer. RCRA, in fact, has permitted such disposal, with some exceptions. Although most pharmaceutical contamination in our waters comes from secretions, disposal of pharmaceuticals into sewers is as a cause for concern.

These circumstances created a clear need for a separate RCRA program for management of pharmaceutical waste generated by healthcare facilities.

The EPA published their final rule, “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” on February 22, 2019.

According to the EPA’s Rule Summary:

  • “This final rule establishes cost- saving, streamlined standards for handling hazardous waste pharmaceuticals to better fit the operations of the healthcare sector while maintaining protection of human health and the environment.
  • Importantly, this final rule will make our drinking and surface water safer and healthier by reducing the amount of hazardous waste pharmaceuticals entering our waterways by 1,644 to 2,300 tons on an annual basis by prohibiting all facilities subject to the rule from sewering them. This action will help address the issue highlighted by a growing body of publicly available studies documenting the presence of pharmaceuticals in drinking and surface waters as well as their negative impacts to aquatic and riparian ecosystems.”

Who is Affected?

  • Healthcare facilities (human or animal)
  • Reverse distributors

Who is Not Affected?

  • Pharmaceutical manufacturers
  • Households
  • Farmers, Ranchers, Fisheries
  • RCRA-Permitted TSDFs

Highlights of the Final Rule

Healthcare facilities and reverse distributors will manage their hazardous waste pharmaceuticals (HWPs) under this new set of standards in lieu of the existing hazardous waste generator regulations. Here are a few examples of changes under the new rule:

  • Sewering Ban: health care facilities covered by the rule are prohibited from discharging HWPs to a sewer system that passes through a POTW. This will go into effect August 21, 2019 regardless of a state’s RCRA status.
  • Empty Containers: under the new regulations, certain stock, dispensing and unit-dose containers including syringes and IV bags are considered “empty” and therefore not regulated as hazardous waste under RCRA, even if minor pharmaceutical residue remains, provided they have been emptied using the practices commonly employed to remove materials from that type of container or have been fully administered to a patient.
  • OTC Nicotine Replacement Therapies: Under the new rule, over the counter Nicotine replacement therapies, including lozenges, gum and patches, are exempt from the P075 waste code.
  • Overlapping regulations for wastes that carry additional hazards are addressed in the final rule. Examples include DEA-regulated HWPs, “dual waste” (i.e., HWP and medical) and “mixed waste,” or HWPs with a radioactive component.
  • Definitions for Subpart P: Some RCRA definitions have been added, including
    these: healthcare facility, long-term care facility, reverse distributor, noncreditable hazardous waste pharmaceutical, and potentially creditable hazardous waste pharmaceutical.

Waste Pharmaceuticals in California
Note that many of these provisions do not apply to waste pharmaceuticals at California facilities. In California, pharmaceutical wastes that meet California’s definition of hazardous waste (“non-RCRA hazardous waste”) are subject to the Medical Waste Management Act (“MWMA” – Division 104, Part 14 California Health and Safety Code). Pharmaceutical wastes that are regulated under RCRA, such as bulk chemotherapy drugs, P-listed waste (nicotine, Coumadin/warfarin, arsenic trioxide, etc.), U-listed waste (mercury, chloroform, etc.) and characteristic hazardous waste (aerosol propellants, M-Cresol, etc. are excluded from the MWMA regulations and must be managed as hazardous waste. The MWMA establishes specific requirements for storage, management and disposal of medical waste pharmaceuticals from California facilities.

Implementation of the EPA Pharmaceutical Rules
The prohibition on disposing of HWPs via sewer is effective in ALL states beginning August 21, 2019.

The amendment to the Nicotine listing only applies to unauthorized states effective August 21,2019. Since it is less stringent, authorized states are not required to adopt the amendment.

Subpart P: authorized states have until July 1, 2021 to adopt. If a state requires a statutory amendment, it has until July 1, 2022 to adopt.

For more information:
View the Federal Register’s published rule here:
https://www.federalregister.gov/documents/2019/02/22/2019-01298/management-standards-for-hazardous-waste-pharmaceuticals-and-amendment-to-the-p075-listing-for

View the California Medical Waste Management Act here:
https://www.cdph.ca.gov/Programs/CEH/DRSEM/CDPH%20Document%20Library/EMB/MedicalWaste/
MedicalWasteManagementAct.pdf

The EPA has also posted a Webinar, which can be viewed here:
https://clu-in.org/conf/tio/HazWastePharmaceuticals_040219/

Should you need more information on this new rule or help in disposing of any regulated waste in the safest, most sustainability-minded way, please reach out to me or any of my colleagues. We will be glad to assist.

– ACTenviro Account Manager

ALL BRANCH LOCATIONS

*ACTenviro has National service and consulting capabilities across the US

California
San Jose (Corporate Offices and Working
Facility)
967 Mabury Road
San Jose, CA 95133
Phone: (408) 548-5050
24.7 ER: (866) 348-2800
Fax: (408) 548-5052
Dixon
6940 Tremont Road
Dixon, CA 95620
Phone: (800) 559-3274
Los angeles
12235 Los Nietos Road
Santa Fe Springs, CA 90670
Phone: (714) 545-2191
SUNNYVALE
1210 Elko Drive
Sunnyvale, CA 94089
Phone: (408) 548-5050
Fax: (408) 548-5052
san diego
2010 W Mission Road
Escondido, CA 92029
Phone: (858) 925-2500
sacramento
4 Wayne Court, Building 9
Sacramento, CA 95829
Phone: (916) 299-4228
inland empire
600 Iowa Street
Redlands, CA 92373
Phone: (909) 406-4400
merced
265 Riggs Avenue
Merced, CA 95341
Phone: (209) 722-4228
Fax: (209) 722-8228
Oregon
portland
13600 SE Ambler Road
Clackamas, OR 97015
Phone: (971) 279-6780
New Mexico
ALBUQUERQUE
208 Murray Road SE
Albuquerque, NM 87105
Phone: (505) 445-9400
Fax: (505) 445-9401
ACTreatment (TSDF)
6137 Edith Boulevard NE
Albuquerque, NM 87107
Phone: (505) 349-5220
Fax: (505) 344-7986
El Paso
511 Highway 213
Chaparral, NM 88081
Phone: (575) 824-0164
ARIZONA
Phoenix
6212 S 75th Avenue #4
Laveen Village, AZ 85339
Phone: (602) 842-9160
Tucson
5568 N Camino De La Tierra
Tucson, AZ 85705
Phone: (520) 471-4672
Texas
dallas
4730 Bronze Way
Dallas, Texas 75236
Phone: (469) 518-6400
Fax: (469) 518-6402
HOUSTON
1700 North E Street
La Porte, TX 77571
Phone: (713) 568-2500
Fax: (713) 568-2501
Colorado
denver
4295 Kearney Street
Denver, CO 80216
Phone: (720) 386-2900
Pennsylvania
Fort Washington
500 Office Center Drive
Suite 400
Fort Washington, PA 19034
Phone: (626) 224-1666
Washington
spokane
1809 E. Houston Ave
Spokane, WA 99217
Phone: (509) 503-1300
Fax: (509) 503-1301
seattle
2923 S J Street
Tacoma, WA 98409
Phone: (253) 357-5200
Fax: (253) 357-5201
Copyright © 2024 ACTenviro. All Rights Reserved
Anthem MRF | Resources | Glossary | Terms & Conditions | Privacy Policy
footer logo
crossmenu